Notice to Explain SAMPLE FORM (First Notice)PoL Sangalang
This is one of my suggested format for the FIRST NOTICE in the observance of procedural process under the Philippine law on termination of employment (otherwise known as the "two notice rule" or "2 notice rule").
This format is based on the requirements of the Omnibus Rules Implementing the Labor Code of the Philippines and latest jurisprudence from the Philippine Supreme Court.
This is the first FORMAL step in terminating an employee based on JUST CAUSE.
What not to wear: dress codes and discrimination - employment webinar - James...Browne Jacobson LLP
Watch the webinar: https://www.brownejacobson.com/training-and-resources/training/training-videos/2016/07/what-not-to-wear-dress-codes-and-discrimination-webinar-july-2016
Workplace dress codes have been at the forefront of several high profile cases recently, and recent media interest has heightened many employers’ interest. Can you insist that front of house staff wear high heels? What happens when an organisation’s dress code conflicts with an employee’s desire to wear religious clothing? Is it discriminatory to have different dress codes for men and women? What should transgender employees be asked to wear?
Designing a dress code is not always as straightforward as it may seem - how do employers avoid claims of discrimination or breaching employees’ human rights?
In this webinar we distil the recent UK and EU case law into practical guidance for employers on:
• how to avoid legal challenges and conflicts with employees
• setting dress codes and avoiding common pitfalls
• how to deal with challenges raised by employees.
If your organisation implements a dress code, watch our 30 minute webinar: https://www.brownejacobson.com/training-and-resources/training/training-videos/2016/07/what-not-to-wear-dress-codes-and-discrimination-webinar-july-2016
Notice to Explain SAMPLE FORM (First Notice)PoL Sangalang
This is one of my suggested format for the FIRST NOTICE in the observance of procedural process under the Philippine law on termination of employment (otherwise known as the "two notice rule" or "2 notice rule").
This format is based on the requirements of the Omnibus Rules Implementing the Labor Code of the Philippines and latest jurisprudence from the Philippine Supreme Court.
This is the first FORMAL step in terminating an employee based on JUST CAUSE.
What not to wear: dress codes and discrimination - employment webinar - James...Browne Jacobson LLP
Watch the webinar: https://www.brownejacobson.com/training-and-resources/training/training-videos/2016/07/what-not-to-wear-dress-codes-and-discrimination-webinar-july-2016
Workplace dress codes have been at the forefront of several high profile cases recently, and recent media interest has heightened many employers’ interest. Can you insist that front of house staff wear high heels? What happens when an organisation’s dress code conflicts with an employee’s desire to wear religious clothing? Is it discriminatory to have different dress codes for men and women? What should transgender employees be asked to wear?
Designing a dress code is not always as straightforward as it may seem - how do employers avoid claims of discrimination or breaching employees’ human rights?
In this webinar we distil the recent UK and EU case law into practical guidance for employers on:
• how to avoid legal challenges and conflicts with employees
• setting dress codes and avoiding common pitfalls
• how to deal with challenges raised by employees.
If your organisation implements a dress code, watch our 30 minute webinar: https://www.brownejacobson.com/training-and-resources/training/training-videos/2016/07/what-not-to-wear-dress-codes-and-discrimination-webinar-july-2016
Recalls: The First Smoke of A Mass Tort -- Overview of a Recall of an FDA-Reg...Michael Swit
January 2005 Presentation to Food & Drug Law Institute (FDLI) Conference on Products Liability for FDA Regulated Products, with a focus on:
• Review key rules or requirements that apply to recalls
– What is a recall and what is not
– What FDA’s authority is relative to recalls –e.g., can it order a recall?
– How FDA deals with recalls and how industry interacts with the agency, including
• information FDA expects from a recalling firm
• How FDA expects public notification to be handled
• Classifying recalls by health hazard profile
– Handling the recall logistically
• Understand how recall handling can set the tone for potential products liability exposure post-recall
This panel is especially suited for those attendees who are already familiar with the section 15 reporting obligations and have interacted with Compliance/Field staff on investigations and actual recalls. Includes discussion of priority issues related to being prepared in the event a recall is necessary, working effectively with Field investigators during inspections, how to improve recall effectiveness through the appropriate remedy choice and how to ensure safe adequate disposal of recalled products.
Overview of CPSC, Health Canada, and Profeco cooperation, legislation, joint recalls, and including a case study of stroller regulatory requirements in all 3 jurisdictions.
Visit us at www.insurancecommunitycenter.com to find the recorded presentation with the narrator!
Flip through the slides of this presentation and find out:
What does AB 2774 do?
What does it mean to the employer?
What are the implications?
What steps can an employer take to be pro-active and prepared?
What impact could this new law have on brokers?
Contact@insurancecommunitycenter.com
Webinar, 10/18: Attorney Bradley Merrill Thompson examines what the current process is for deciding when to recall a product and what the future holds.
In this presentation we want to outline the principles of medical device regulations and the 510(k) Premarket notification process for an efficient product approval with the FDA.
2014 updates for durable infant and toddler products. How to locate CPSC data on regulatory non-compliance notices, which are also called "letters of advice" (LOAs). The referenced Excel table will be updated frequently with the names of the firm, the foreign manufacturer, and other information. Businesses may integrate this information into their compliance workflows to assist them in sourcing safe & compliant consumer products.
A briefing for the Consumer Product Safety Commission by CPSC staff from the Directorate for Engineering Sciences, Division of Mechanical Combustion Engineering.
Recalls: The First Smoke of A Mass Tort -- Overview of a Recall of an FDA-Reg...Michael Swit
January 2005 Presentation to Food & Drug Law Institute (FDLI) Conference on Products Liability for FDA Regulated Products, with a focus on:
• Review key rules or requirements that apply to recalls
– What is a recall and what is not
– What FDA’s authority is relative to recalls –e.g., can it order a recall?
– How FDA deals with recalls and how industry interacts with the agency, including
• information FDA expects from a recalling firm
• How FDA expects public notification to be handled
• Classifying recalls by health hazard profile
– Handling the recall logistically
• Understand how recall handling can set the tone for potential products liability exposure post-recall
This panel is especially suited for those attendees who are already familiar with the section 15 reporting obligations and have interacted with Compliance/Field staff on investigations and actual recalls. Includes discussion of priority issues related to being prepared in the event a recall is necessary, working effectively with Field investigators during inspections, how to improve recall effectiveness through the appropriate remedy choice and how to ensure safe adequate disposal of recalled products.
Overview of CPSC, Health Canada, and Profeco cooperation, legislation, joint recalls, and including a case study of stroller regulatory requirements in all 3 jurisdictions.
Visit us at www.insurancecommunitycenter.com to find the recorded presentation with the narrator!
Flip through the slides of this presentation and find out:
What does AB 2774 do?
What does it mean to the employer?
What are the implications?
What steps can an employer take to be pro-active and prepared?
What impact could this new law have on brokers?
Contact@insurancecommunitycenter.com
Webinar, 10/18: Attorney Bradley Merrill Thompson examines what the current process is for deciding when to recall a product and what the future holds.
In this presentation we want to outline the principles of medical device regulations and the 510(k) Premarket notification process for an efficient product approval with the FDA.
2014 updates for durable infant and toddler products. How to locate CPSC data on regulatory non-compliance notices, which are also called "letters of advice" (LOAs). The referenced Excel table will be updated frequently with the names of the firm, the foreign manufacturer, and other information. Businesses may integrate this information into their compliance workflows to assist them in sourcing safe & compliant consumer products.
A briefing for the Consumer Product Safety Commission by CPSC staff from the Directorate for Engineering Sciences, Division of Mechanical Combustion Engineering.
Regulatory cooperation should be relevant and responsive to real world challenges. This panel provides perspectives on new trends, products, and hazards and what can be done within the North America Cooperation framework. Points of focus: Cooperation and best practices, Policy Alignment, Consumer messaging.
Presenters: Agustin Adame, Consultant; Belinda May, ICPHSO President and Partner, Dentons US LLP; Carol Pollack-nelson, Ph.D. Independent Safety Consulting; Gene Rider, Eponent, Principal.
Hazards associated with high energy density batteries are common to all three jurisdictions. How can risk to consumers be reduced and what steps have already been taken by stakeholders in North America? Points of focus: 1. Industry's product safety processes pre- and post-market. 2. Understanding and eliminating failure modes. Challenges and how can stakeholders and regulators work together to improve safety?
Presenters: Charlie Monahan, Director, Regulatory Compliance, Panasonic; Don Mays, Chief Safety and Quality Officer, Samsung; Rick Brenner, President, Product Safety Advisors, LLC.
Stakeholders and regulators discuss the benefits and challenges posed by the rapid expansion of e-commerce. Discussion of industry processes and best practices. How can regulators help platforms help their sellers and consumers?
Presenters: Doug Hyland, Compliance Program Manager, zulily; Stuart Schmidt, Manager, Trade Compliance, UPS; Carlos Ponce Beltran, Deputy Attorney for Telecommunications, PROFECO.
Presentation by Blake G. Rose, Director, Defect Investigations Division Office of Compliance and Field Operations on CPSC Review of Recall Process and Standard Notifications.
Presentation Date: July 25, 2017
Understanding the Challenges of Street ChildrenSERUDS INDIA
By raising awareness, providing support, advocating for change, and offering assistance to children in need, individuals can play a crucial role in improving the lives of street children and helping them realize their full potential
Donate Us
https://serudsindia.org/how-individuals-can-support-street-children-in-india/
#donatefororphan, #donateforhomelesschildren, #childeducation, #ngochildeducation, #donateforeducation, #donationforchildeducation, #sponsorforpoorchild, #sponsororphanage #sponsororphanchild, #donation, #education, #charity, #educationforchild, #seruds, #kurnool, #joyhome
Jennifer Schaus and Associates hosts a complimentary webinar series on The FAR in 2024. Join the webinars on Wednesdays and Fridays at noon, eastern.
Recordings are on YouTube and the company website.
https://www.youtube.com/@jenniferschaus/videos
Donate to charity during this holiday seasonSERUDS INDIA
For people who have money and are philanthropic, there are infinite opportunities to gift a needy person or child a Merry Christmas. Even if you are living on a shoestring budget, you will be surprised at how much you can do.
Donate Us
https://serudsindia.org/how-to-donate-to-charity-during-this-holiday-season/
#charityforchildren, #donateforchildren, #donateclothesforchildren, #donatebooksforchildren, #donatetoysforchildren, #sponsorforchildren, #sponsorclothesforchildren, #sponsorbooksforchildren, #sponsortoysforchildren, #seruds, #kurnool
Monitoring Health for the SDGs - Global Health Statistics 2024 - WHOChristina Parmionova
The 2024 World Health Statistics edition reviews more than 50 health-related indicators from the Sustainable Development Goals and WHO’s Thirteenth General Programme of Work. It also highlights the findings from the Global health estimates 2021, notably the impact of the COVID-19 pandemic on life expectancy and healthy life expectancy.
Presentation by Jared Jageler, David Adler, Noelia Duchovny, and Evan Herrnstadt, analysts in CBO’s Microeconomic Studies and Health Analysis Divisions, at the Association of Environmental and Resource Economists Summer Conference.
Jennifer Schaus and Associates hosts a complimentary webinar series on The FAR in 2024. Join the webinars on Wednesdays and Fridays at noon, eastern.
Recordings are on YouTube and the company website.
https://www.youtube.com/@jenniferschaus/videos
This session provides a comprehensive overview of the latest updates to the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (commonly known as the Uniform Guidance) outlined in the 2 CFR 200.
With a focus on the 2024 revisions issued by the Office of Management and Budget (OMB), participants will gain insight into the key changes affecting federal grant recipients. The session will delve into critical regulatory updates, providing attendees with the knowledge and tools necessary to navigate and comply with the evolving landscape of federal grant management.
Learning Objectives:
- Understand the rationale behind the 2024 updates to the Uniform Guidance outlined in 2 CFR 200, and their implications for federal grant recipients.
- Identify the key changes and revisions introduced by the Office of Management and Budget (OMB) in the 2024 edition of 2 CFR 200.
- Gain proficiency in applying the updated regulations to ensure compliance with federal grant requirements and avoid potential audit findings.
- Develop strategies for effectively implementing the new guidelines within the grant management processes of their respective organizations, fostering efficiency and accountability in federal grant administration.
3. Promotes robust design and testing of products during development
and in the manufacturing/assembly process
Promotes early detection of potentially unsafe products
Facilitates efficient and effective implementation of CPSC reporting
obligations and Corrective Action Plans, including recalls and reverse
logistics
Avoid civil penalties:
“Reasonable and effective program or system for collecting and analyzing
information related to safety issues.” 16 C.F.R. §1119.4(b).
History of non-compliance. 16 C.F.R. §1119.4(b)(2).
Protect consumers
4. Reporting requirements of Section 15(b) of CPSA (15 U.S.C. §2064)
A Firm is required to immediately report when it obtains information which
reasonably supports the conclusion that a consumer product:
Fails to comply with an applicable consumer product safety rule or a
voluntary standard which is relied on under Section 9 (of the CPSA),
Fails to comply with any other rule, regulation, standard or ban under
the CPSA or other acts enforced by the CPSC,
Contains a defect which could create a substantial product hazard, or
Creates an unreasonable risk of serious injury or death.
5. Knowing violations:
(1) actual knowledge, or
(2) presumed knowledge
If the firm receives relevant information from various sources, but does
not have a process to organize it, analyze it and elevate issues within the
organization, it may constitute a knowing violation of 15(b).
Important to develop a compliance program that ensures the right
people at your firm are informed of safety information and have the
authority to file a report.
Important for a Firm to know WHO, WHAT, and WHEN
6. Not just people to whom reports are made; includes individuals in
the reporting chain
The Firm is deemed to have obtained reportable information when
[safety related information] has been received by an official or
employee who may reasonably be expected to be capable of
appreciating the significance of the information. 16 C.F.R.
§1115.11(a).
Expected that the information will reach the CEO or the official
responsible for 15(b) compliance within 5 days. 16 C.F.R § 1115.14(b).
Review your Firm’s organizational structure, roles and responsibilities.
Members could include Safety or Quality staff, Customer Service Personnel,
Risk Management staff, Engineers, General Counsel…
7. Engineering, quality control or production data
Information about safety-related production or design changes
Product liability suits and/or claims for personal injury and damage
Information from an independent testing laboratory
Incident complaints from consumers or consumer groups
Information received from the commission (360 reports) or other governmental agencies
Requests to return a product or for replacement or credit; by distributors/retailers to the
manufacturer and requests from the manufacturer that the product be returned
Warranty claims
Product repairs or returns
Premarket and production testing
Compliance with applicable mandatory and voluntary safety standards
16 C.F.R. § 1115.12(f). 16 C.F.R. §1119.4(b).
8. Death or grievous bodily injuries: Defect, noncompliance caused, may have caused,
contributed to the causing, or could cause mutilation, amputation/dismemberment,
disfigurement, loss of important bodily functions, debilitating internal disorders, severe burns,
severe electrical shocks, and injuries likely to require extended hospitalization. 16 C.F.R. §
1115.12(d).
Marbles, small balls, balloons or small parts in a toy or game on which a child choked and
died, suffered serious injury, ceased breathing, or was treated by a medical professional; 16
C.F.R. § 1117.3 (MDRI)
Section 37: Manufacturers: Three civil actions filed in federal or state court for death or
grievous bodily injury within a 24 months resulting in settlement or plaintiff’s judgment.
Report: 30 days.
The CPSC “would expect to receive 15b reports long before the obligation to report
under Rule 37 arises since Firms frequently obtain reportable information before
settlements or judgments in their product liability lawsuits.” 16 C.F.R. § 1115.7.
Think Globally: If the product is sold outside the U.S., information about its use, experience,
performance, design, or manufacture should be considered. 16 C.F.R. §1115.12(f).
9. What is information that “reasonably suggests the existence of a defect”?
Dictionary definition
Regulation broadly defines:
Defect resulting from manufacturing or production errors
Defects from contents, materials, construction, finish, packaging,
warnings, and/or instructions
Design defect that presents a risk of injury:
Examine utility, nature of the risk of injury, necessity, population
exposed, obviousness of the risk, adequacy of warnings and instructions
to mitigate the risk, role of consumer misuse and foreseeability of
misuse; commission’s expertise; case law interpreting federal health and
safety statutes; case law in products liability, other relevant factors
16 C.F.R. § 1115.4
10. Does defect/noncompliance, because of the:
Pattern of Defect, or
Number of Defective Products Distributed, or
Even one defective product can present a substantial risk of injury if the
injury which might occur is serious and/or if the injury is likely to occur.
Severity of the Risk, or
A risk is severe if the injury which might occur is serious and/or likely to
occur. In considering likelihood of injury, consider the number of injuries
reported, intended[ use] or reasonably foreseeable use or misuse of the
product, and population exposed (children, elderly, handicapped).
other relevant factors
create a substantial risk of injury to the public. 16 C.F.R. §1115.12.(g).
11. No
Still need to evaluate whether the information reasonably
supports a conclusion that the product could create an
unreasonable risk of serious injury or death—if it is possible,
report. 16 C.F.R. § 1115.6(a).
Do not wait for a serious injury or death to actually occur before
reporting. 16 C.F.R. §1115.6(a).
12. Reports from experts
Test reports
Product liability lawsuits or claims
Consumer or customer complaints
Quality control data
Scientific or epidemiological studies
Reports of injury
Information from other firms or governmental entities
Other relevant information
Judgment: “The CPSC will attach considerable significance if a firm learns that a
court or jury has determined that one of its products has caused a serious injury or
death and a reasonable person could conclude . . . that the product creates an
unreasonable risk of serious injury or death.” 16 C.F.R. §1115.6(a)
13. A grievous bodily injury 16 C.F.R. §1115.12(d)
Injury necessitating hospitalization requiring actual medical or
surgical treatment
Fractures, lacerations requiring sutures, concussions, injuries to the
eye/ ear/internal organs requiring medical treatment, and injuries
necessitating absence from school or work of more than one day
Evaluate chronic or long term health effects as well as immediate
injuries
Assess the RISK of serious injury, not just actual injuries
16 C.F.R. §1115.6(c)
14. Always monitor to ensure compliance with standards.
Mandatory Standard:
If violate, report.
If comply, still may need to report a defect: Compliance does not relieve
a firm from the need to report a defect that creates a sph, but will be
considered by staff in the determination of whether/what type of
corrective action is required. 16 C.F.R. §1115.8(b).
Voluntary Standards: Compliance with a voluntary standard
may be relevant to the CPSC staff’s preliminary determination of
whether the product presents a substantial product hazard.
15. Immediately: 24 hours (weekends, holidays excluded). 16 C.F.R.
§1115.14(e)
Don’t wait to accumulate incident or injury reports: may arise upon
receipt of first information regarding a potential hazard, noncompliance
or risk. 16 C.F.R. §1115.14(c).
10 days for investigation. 16 C.F.R. 1115.14(d)
A firm is assumed to have received and considered all information
which would have been available to it had it conducted a reasonable,
expeditious and diligent investigation regardless of the information it
actually has in its possession. 16 C.F.R. §1115.14(d)
16. Noah AnStraus and Lauren Kleinman
Trial Attorneys
Office of General Counsel
Division of Compliance
This presentation has not been reviewed or approved by the
Commission and may not reflect their views.
17. Create a system to collect, consolidate and ensure information is
properly analyzed.
18. Training – Don’t just talk about it, do it!
New employee training
Bi-annual or annual refresher training
Practice and Audit; Incorporate Lessons Learned
Allows for review and evaluation of the compliance program to facilitate
its continuous improvement
Ensures that training is effective and not just a box to check
19. Tailor the program to your firm’s specific needs
Make sure all employees and other relevant parties (e.g.
suppliers, distributors) are aware of and understand the
program
The program is not a static document – it needs to grow and
evolve with your firm
20. Have a recall plan in place to enable quick action. The ISO standards
below may provide additional guidance:
ISO 10377 Consumer Product Safety Guidelines
ISO 10393 Consumer Product Recall Guidelines
ISO 19600 Compliance Management Systems Guidelines
ISO 31000 Risk Management: Principles and Guidelines
21. Make safety a priority at the design stage; consult CPSC’s Handbook for
Manufacturing Safer Consumer Products for guidance and best practices and
conduct usability testing as part of the development process
Conduct adequate and relevant premarket and production testing to ensure
products meet or exceed safety requirements in relevant mandatory and
voluntary safety standards
Exercise due care when relying on a supplier by taking affirmative steps, such
as:
Including contractual provisions requiring compliance with specifications and quality
programs
Visiting manufacturing locations
Spot-checking products for ongoing compliance with safety requirements
Conduct regular audits to confirm compliance within your firm and among
your suppliers
22. Establish systematic procedures for collecting the information to be reviewed and
evaluated for potential safety issues
Consider multiple sources of information
Types of incident information to collect:
Date of report
Consumer contact information (name, address, email, and phone)
Product name, make, model, serial number, date code, and any other identifying
information on the product or packaging
Incident details such as:
Date of incident
Circumstances surrounding incident
Injury/medical attention, medical records if appropriate, and photographs
Collection of incident sample, if available
23. Establish a central database to track information; ensure early issue
identification and closing open issues:
Set up a system to capture all incidents and route potential safety related
incidents to the compliance team
Make sure that your databases speak to one another
Ensure that employees are trained to recognize safety related issues, so
they are prepared to elevate these issues to management as soon as they
see them
Have a system in place to regularly analyze what is contained in the
Database to make certain that issues are identified and addressed as soon
as possible
24. Safety issues will eventually surface, but it is best to get ahead of
them
Make employees comfortable in reporting safety issues; create a
confidential path for sensitive issues
Ensure that information gets to the right people in your
organization based on its structure and roles and responsibilities
25. Maintain a culture that emphasizes and values product safety,
compliance with CPSC safety requirements and voluntary
standards, and a comprehensive quality assurance program
Oversight of compliance by the firm’s responsible official will
facilitate prompt disclosure to senior management of any
deficiencies and allow for consistent decision making
Develop a mechanism for elevating product safety reports to
senior management
26. Understand your legal responsibility to report information to the
CPSC about the product if it:
(i) fails to comply with a CPSC rule, regulation, standard or ban
(ii) contains a defect which could create a substantial product hazard
(iii) creates an unreasonable risk of serious injury or death
Keep up with the CPSC’s new and updated regulations through
e-mail notification: www.cpsc.gov/email
27. Step-by-step guidance for conducting a recall can be found in the
Recall Handbook: https://www.cpsc.gov/Business--
Manufacturing/Recall-Guidance.
Understand the system(s) of product distribution and the potential
challenges in executing a recall and develop an implementation plan.
Ensure the plan is updated.
Common reverse logistic mistakes:
SKUs were reused; consider how lot or batch controls or model and serial numbers
are used to identify products
computer systems did not communicate with each other
no one individual was identified as the point person for the recall
inventory reports for recalled SKUs were not regularly conducted
sales reports for recalled SKUs were not regularly conducted
register prompts were unclear
28. Establish a records retention system
CPSC staff recommends keeping all compliance-related records for at
least five years
If you are upgrading systems, make sure you can access legacy data
Retention of documents can help identify actions to ensure
future safety and compliance
In the event of a product recall, documentation helps CPSC
understand the efforts you made to provide safe consumer
goods, what went wrong and how it has been corrected
29. 29
This presentation has not been reviewed or approved by the
Commission and may not reflect their views.
Compliance Program Seminar
Reverse Logistics and Adequate Notice
November 1, 2018
30. Public Notice
Remedy
Communication with consumers, retailers, distributors,
and other parties
Destruction or remediation of recalled products
30
31. Reverse logistics is the process of planning, implementing, and
controlling the efficient and effective flow of goods from their
typical final destination for the purpose of recovery or proper
disposal
Physically recovering and properly disposing of products in the
event of a recall or stop sale is just one aspect of a good reverse
logistics plan
A Compliance Program should be comprehensive and anticipate
potential reverse logistics issues that may arise
31
32. Develop a reverse logistics and recall plan before you need it
Rehearse your plan and conduct mock recalls
Identify gaps and define exactly what will happen and who is
responsible for each part of the plan to allow for effective plan
execution
Update to reflect changes in the supply chain
32
33. Alert the entire supply chain
Provide specific instructions for disposition of recalled
products
Provide a recall point of contact
Ensure everyone knows exactly what to do, their role,
and who to contact
Notifications should happen leading up to and
including recall announcement date
33
34. When developing a reverse logistics plan, consider:
Communication avenues
Central location quarantine vs retail destruction
Computer system limitations
Auctioning and selling off
Disposal/recycling procedures
34
35. Tanya Topka, Team Lead
U.S. CPSC, Office of Compliance, Defects Investigation Division
301-504-7594
ttopka@cpsc.gov
35
36. COMPLIANCE PROGRAMS - REGULATED RODUCTS
Carolyn Manley
Team Lead, Regulated Children’s Products
Regulatory Enforcement Division
Office of Compliance and Field Operations
This presentation has not been reviewed or approved by the
Commission and may not reflect their views.
37. Purpose of Compliance Program
What is the purpose of developing a compliance program?
For a company to develop internal safe guards to ensure their
products comply with regulations.
38. Developing a Compliance Program:
Knowing the Statute and Requirements
38
Federal Hazardous Substances Act (FHSA)
Small parts, labeling for toys and games, lead in paint, lead
content, art materials
Consumer Product Safety Act (CPSA)
Phthalates, ASTM F-963, durables, tracking label, certification
Flammable Fabrics Act (FFA)
Poison Prevention Packaging Act (PPPA)
Refrigerator Safety Act (RSA)
Virginia Graeme Baker Pool & Spa Safety Act
Children’s Gasoline Burn Prevention Act (CGBPA)
39. Common Problems
These common problems can be avoided:
Products not meeting mandatory standards
Products being detained at the port
Products not tested to the applicable requirements
No Children’s Product Certification or General Certificate of
Conformity
Appropriate Test Reports
40. Developing a Compliance Program:
Small Parts Requirements
(Toys for children under 3 years of age)
40
Toys and other articles for children under 3 years of
age must not contain any small parts before and
after use and abuse testing
Small parts are articles that fit into small parts
cylinder.
41. Which requirements apply?
Age 19+ months
-Lead content
-Lead and other heavy metals
surface coating
-Phthalates
-Small parts
-ASTM Battery operated toy
-ASTM Sound producing toy
-Tracking label
-Certification
42. Which requirements apply?
Age 19~35 months, 29 pieces,
larger size blocks that will not
fit into small parts cylinder
Age 3+ years, 102 pieces,
smaller size blocks that fit
into small parts cylinder
-Lead content
-Phthalates
-Small parts
-Tracking label
-Certification
-Phthalates
-Lead content
-Small parts warning label
-Tracking label
-Certification
43. Developing a Compliance Program:
Requirements for Labeling for Toys and Games
(Toys for children 3 years of age and above)
43
Small parts: age 3-
less than 6
Balloons: all latex balloons
Small ball: age 3 and older
Toy contains a small ball: age 3 -
less than 8
Marble: age 3 and older
Toy contains a marble: age 3- less
than 8
44. Developing a Compliance Program:
Requirements for Labeling for Toys and Games
(Toys for children 3 years of age and above)
Before the firm instituted
a compliance program
After the firm instituted
a compliance program
45. Developing a Compliance Program:
Durable Infant and Toddler Products
What is a durable infant or toddler product?
Section 104 (b) of the Consumer Product Safety
Improvement Act – Danny Keysar Child Product Safety
Notification Act (Danny’s Law)
“Durable infant or toddler product” is defined as a
durable product intended for use, or that may be
reasonably expected to be used, by children under the
age of 5 years.
The products listed in the Commission’s regulations at
16 CFR 1130.2.
45
46. LIST OF DURABLE INFANT OR TODDLER PRODUCTS
ASTM
• Gates and Enclosures
47. Common Problems with Durables
Ensuring that third-party testing laboratories
are CPSC-accepted and accredited to test to the
mandatory standards.
Ensuring that third-party testing is being
conducted to the most up-to-date version of the
standards approved by the Commission.
Ensuring that durables have a registration form
attached to the product.
Ensuring that the products and their packaging
are labeled in accordance with the registration
and tracking label requirements.
48. EXAMPLE OF REGISTRATION FORM
Purpose statement
Postage paid
Manufacturer’s U.S.
mailing address
Manufacturer’s U.S. contact information:
address and registration website
If no registration website, email is
required.
Consumer address
and contact info
Pre-printed
product info.
Consumer
keeps
Consumer
mails out
ABC
ABC
123
123
Jan 1, 2018
Jan 1, 2018
50. Developing a Compliance Program:
Lead Limit Requirements
Lead content: cannot exceed 100 ppm in children’s
products
Lead in paint: cannot exceed 90 ppm for surface
coating on children’s products
Commission has determined that certain materials
would not contain lead, and therefore, do not
require lead content testing. Some of the materials
that do not contain lead are: wood, paper, most
textiles and natural fibers (dyed and undyed),
plant and animal-derived materials, and certain
precious metals. A complete list of materials can be
found at 16 C.F.R. § 1500.91(d).
51. Developing a Compliance Program:
PPPA - Special Packaging Requirements
Special Packaging is packaging that is designed or constructed to be significantly
difficult for children under five years of age to open or obtain a toxic or harmful
amount of the substance contained therein within a reasonable time and not difficult
for normal adults to use properly..” 15 U.S.C. § 1471(4)
32 Substances requiring Special Packaging are listed at 16 C.F.R.
§ 1700.14 (a)(1-13, 15-33)
Performance specifications for Special Packaging can be found in 16 C.F.R. §
1700.15.
How to test: the Testing Protocol for Special Packaging is at 16 C.F.R. § 1700.20.
Manufacturers and importers of certain general use products (i.e., non-
children’s products) for which consumer product safety rules apply, must
certify, in a written General Certificate of Conformity (GCC) based on testing or
a reasonable testing program, that their products comply with those applicable
rules.
51